Information:
Fel:
ID
20288
Beskrivning
EMD 128130 for the Treatment of Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00009048
Länk
https://clinicaltrials.gov/show/NCT00009048
Nyckelord
Versioner (1)
- 2017-02-19 2017-02-19 -
Uppladdad den
19 februari 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Parkinson's Disease NCT00009048
Eligibility Parkinson's Disease NCT00009048
- StudyEvent: Eligibility
Similar models
Eligibility Parkinson's Disease NCT00009048
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
contraceptive methods
Item
females must be either at least one year post-menopausal, or using an adequate contraceptive method for at least one month prior to and during participation in this study.
boolean
C0700589 (UMLS CUI [1])
idiopathic parkinsons disease
Item
patients will carry the diagnosis of idiopathic parkinson's disease based on the presence of a characteristic clinical history and neurologic findings.
boolean
C0030567 (UMLS CUI [1])
levodopa-associated motor response
Item
patients will have relatively advanced disease with levodopa-associated motor response complications, including peak-dose dyskinesias and wearing-off fluctuations.
boolean
C1853846 (UMLS CUI [1])
illness
Item
patients with the presence or history of any medical condition that can reasonably be expected to subject the patient to unwarranted risk will be excluded.
boolean
C0221423 (UMLS CUI [1])
clinically significant laboratory abnormalities
Item
patients with clinically significant laboratory abnormalities including liver enzyme elevations more than two times the upper limit of normal will be excluded.
boolean
C1853129 (UMLS CUI [1])
levodopa responsive
Item
patients who are unable to be treated with levodopa/carbidopa alone or with a single, relatively short-acting dopamine agonist will be excluded.
boolean
C1853846 (UMLS CUI [1])
parkinson
Item
patients with a form of parkinsonism other than idiopathic pd will be excluded.
boolean
C0030567 (UMLS CUI [1])
concomitant medications
Item
patients with unacceptable prior/concomitant medications will be excluded.
boolean
C2347852 (UMLS CUI [1])
contraceptive methods and pregnancy
Item
no pregnant women. female and male patients must be practicing effective means of birth control.
boolean
C0700589 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0032961 (UMLS CUI [2])
prior brain surgery
Item
patients with prior bilateral surgical intervention for the treatment of parkinsonian symptoms, i.e. deep brain stimulation, pallidotomy, fetal tissue transplantation will be excluded.
boolean
C0455610 (UMLS CUI [1,1])
C0195775 (UMLS CUI [1,2])
C0195775 (UMLS CUI [1,2])
risk for hypotension
Item
patients at risk for hypotension, cardiac arrhythmia, and/or myocardial ischemia secondary to intravenous levodopa challenge will not be eligible.
boolean
C0035648 (UMLS CUI [1,1])
C0020649 (UMLS CUI [1,2])
C0035648 (UMLS CUI [2,1])
C0003811 (UMLS CUI [2,2])
C0035648 (UMLS CUI [3,1])
C0151744 (UMLS CUI [3,2])
C0020649 (UMLS CUI [1,2])
C0035648 (UMLS CUI [2,1])
C0003811 (UMLS CUI [2,2])
C0035648 (UMLS CUI [3,1])
C0151744 (UMLS CUI [3,2])
cognitive impairment
Item
patients with cognitive impairment (mmse less than 25) will not be eligible.
boolean
C0338656 (UMLS CUI [1])
serum cortisol and acth stimulation
Item
patients with subnormal serum cortisol responses to acute acth stimulation will be excluded.
boolean
C0236396 (UMLS CUI [1,1])
C1696684 (UMLS CUI [1,2])
C1696684 (UMLS CUI [1,2])